Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities

Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Karyopharm Therapeutics
1 program
1
mitoxantrone hydrochloridePhase 11 trial
Active Trials
NCT02299518CompletedEst. Mar 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Karyopharm Therapeuticsmitoxantrone hydrochloride

Clinical Trials (1)

NCT02299518Karyopharm Therapeuticsmitoxantrone hydrochloride

Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Start: May 2015Est. completion: Mar 2018
Phase 1Completed

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
14m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
14m ago

Office Administrator

SystImmune
14m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
24m ago

Working Student Office Management Support (m/f/d)

Mindpeak
Hamburg
28m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
28m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)